FAILURE OF HYPOMETHYLATING AGENT-BASED THERAPY IN MYELODYSPLASTIC SYNDROMES

類似資料

• Acute Myeloid Leukemia Following Myelodysplastic Syndrome and Failure of Therapy with Hypomethylating Agents: An Emerging Entity With a Poor Prognosis
  著者:: Jabbour, Elias, 等
  出版事項: (2013)
• Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents
  著者:: Takahashi, Koichi, 等
  出版事項: (2016)
• Beyond hypomethylating agents failure in patients with myelodysplastic syndromes
  著者:: Zeidan, Amer M., 等
  出版事項: (2014)
• The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure
  著者:: Nazha, Aziz, 等
  出版事項: (2016)
• Impact of Achievement of Complete Cytogenetic Response on Outcome in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents
  著者:: Jabbour, Elias, 等
  出版事項: (2017)